Janel Long-Boyle - Concepedia

Author

Janel Long-Boyle

Also Known As

J Long-Boyle, J R Long-Boyle, Janel Long-Boyle, Janel Long‐Boyle, Janel R Long-Boyle, Janel R. Long-Boyle, Janel R. Long‐Boyle, Janel Renee Long-Boyle

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco UCSF Benioff Children's Hospital University of Minnesota Stanford University Stanford Medicine

About

Janel Long-Boyle is an author at University of California, San Francisco specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	649
2	Blood Transplantation	6	6	205
3	Health Sciences	2	2	58
4	Allergy	2	2	295
5	Biochemistry	1	1	14

Janel Long-Boyle

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis Imke H. Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, The Lancet Haematology Haemopoietic Cell TransplantationBusulfan ExposureTransplantationAllergyBone Marrow Failure	2016	279
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1 Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, New England Journal of Medicine	2019	258
Primary Immune Deficiency Treatment Consortium (PIDTC) report Linda M. Griffith, Morton J. Cowan, Luigi D. Notarangelo, Journal of Allergy and Clinical Immunology	2013	85
Population Pharmacokinetics of Busulfan in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplant Janel Long-Boyle, Rada Savic, Shirley Qiong Yan, Therapeutic Drug Monitoring	2014	81
Effect of Weight and Maturation on Busulfan Clearance in Infants and Small Children Undergoing Hematopoietic Cell Transplantation Radojka M. Savić, Morton J. Cowan, Christopher C. Dvorak, Biology of Blood and Marrow Transplantation NeonatologyPharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic ModelingPre-clinical Pharmacology	2013	78
Lentiviral Gene Therapy for Artemis-Deficient SCID Morton J. Cowan, Jason Yu, Janelle Facchino, New England Journal of Medicine	2022	67
Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients Vijay Ivaturi, Christopher C. Dvorak, Danna Chan, Biology of Blood and Marrow Transplantation	2017	57
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation Janel Long-Boyle, Kathleen G.E. Green, Claudio G. Brunstein, Bone Marrow Transplantation Hematological MalignancyTransplantationBlood TransfusionHematologyPharmacotherapy	2010	53
Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-Host Disease without Delaying Immune Reconstitution Jason Law, Morton J. Cowan, Christopher C. Dvorak, Biology of Blood and Marrow Transplantation	2012	52
Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients Laura B. Ramsey, Henry H. Ong, Jonathan S. Schildcrout, JAMA Network Open	2020	48

Page 1